Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-05 to 2022-12-06
Current total value of award: $1689.48
Description: 4559429083!TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S